Medical therapy: Calcium oxalate urolithiasis

Urologic Clinics of North America

Volumn 24, Issue 1, 1997, Pages 117-133

  Ruml, L A ^a   Pearle, M S ^a   Pak, C Y C ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOPURINOL; AMILORIDE; CELLULOSE PHOSPHATE; CITRATE POTASSIUM; MAGNESIUM; PHOSPHATE; PYRIDOXINE; THIAZIDE DIURETIC AGENT;

CALCIUM OXALATE STONE; DIET THERAPY; HYPERCALCIURIA; HYPEROXALURIA; HYPERURICOSURIA; METABOLIC DISORDER; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; URINE PH; UROLITHIASIS;

EID: 0031035809     PISSN: 00940143     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0094-0143(05)70358-X     Document Type: Article

References (148)

1. M.H. Abdulhadi P.M. Hall S.B. Streem Can citrate therapy prevent nephrolithiasis? Urology 41 1993 221
2. Ahlstrand C. Tiselius H.-G. Urine composition and stone formation during treatment with acetazolamide Scand J Urol Nephrol 21 1987 225
3. C. Ahlstrand H.G. Tiselius L. Larsson Clinical experience with long-term bendroflumethiazide treatment in calcium oxalate stone formers Br J Urol 56 1984 255
4. B. Almby O. Meirik J. Schönebeck Incidence, morbidity and complications of renal and ureteral calculin (sic) a well defined geographical area Scand J Urol Nephrol 9 1975 249
5. U. Backman B.G. Danielson G. Johansson Effects of therapy with bendroflumethiazide in patients with recurrent renal calcium stones Br J Urol 51 1979 175
6. U. Backman B.G. Danielson G. Johnasson Treatment of recurrent calcium stone formation with cellulose phosphate J Urol 123 1980 9
7. P.W. Baker P. Coyle R. Bais Influence of season, age and sex on renal stone formation in South Australia Med J Aust 159 1993 390
8. P. Barcelo O. Wuhl E. Servitage Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis J Urol 150 1993 1761
9. D.E. Barilla R. Tolentino R.A. Kaplan Selective effects of thiazide on intestinal absorption of calcium in absorptive and renal hypercalciurias Metabolism 27 1978 125
10. D.E. Barilla J.E. Zerwekh C.Y.C. Pak A critical evaluation of the role of phosphate in the pathogenesis of absorptive hypercalciuria Miner Electrolyte Metab 2 1979 302
11. P. Bataille G. Charransol I. Gregoire Effect of calcium restriction on renal excretion of oxalate and the probability of stones in the various pathophysiological groups with calcium stones J Urol 130 1983 218
12. D.S. Bernstein R. Newton The effect of oral phosphate on the formation of renal calculi and on idiopathic hypercalciuria Lancet 2 1966 1105
13. N.J. Blacklock The pattern of urolithiasis in the Royal Navy Hodgkinson A. Nordin B.E.C. Renal Stone Research Symposium 1969 Churchill London 33
14. N.A. Breslau L. Brinkley K.D. Hill Relationship of animal protein-rich diet to kidney stone formation and calcium metabolism J Clin Endocrinol Metab 65 1988 140
15. N.A. Breslau P. Padalino D.J. Kok Physicochemical effects of a new slow-release potassium phosphate preparation (UroPhos-K) in absorptive hypercalciuria J Bone Min Res 10 1995 394
16. A.S. Brickman S.G. Massry J.W. Coburn Changes in serum and urinary calcium during treatment with hydrochorothiazide: Studies on mechanisms J Clin Invest 51 1972 945
17. M. Briggs Vitamin-C-induced hyperoxaluria Lancet 1 1976 154
18. A.E. Broadus J.S. Magee L.E. Mallette A detailed evaluation of oral phosphate therapy in selected patients with primary hyperparathyroidism J Clin Endocrinol Metab 56 1983 953
19. J.G. Brockis A.J. Vevitt S.M. Cruthers The effects of vegetable and animal protein diets on calcium, urate and oxalate excretion Br J Urol 54 1982 590
20. W.J. Burtis L. Gay K.L. Insogna Dietary hypercalciuria in patients with calcium oxalate kidney stones Am J Clin Nutr 60 1994 424
21. M. Butz H. Hoffman G. Kohlbecker Dietary influence on serum and urinary oxalate in healthy subjects and oxalate stone formers Urol Int 35 1980 309
22. Carr Prien Prien E.L. Jr R.K. Babayan Triamterene nephrolithiasis: Renewed attention is warranted J Urol 144 1990 1339
23. A.H. Chalmers D.M. Cowley J.M. Brown A possible etiological role for ascorbate in calculi formation Clin Chem 32 1986 333
24. E. Cicerello F. Merlo G. Gambaro Effect of alkaline citrate therapy on clearance of residual renal stone fragments after extracorporeal shock wave lithotripsy in sterile calcium and infection nephrolithiasis patients J Urol 151 1994 5
25. A. Classen B. Gertz B. Busch Dietary fiber and urolithiasis. Part I: Physical, chemical and hygienic properties of various brans Walker V.R. Sutton R.A.L. Cameron E.C.B. Urolithiasis 1989 Plenum Press New York 867
26. F.L. Coe Treated and untreated recurrent calcium nephrolithiasis in patients with idiopathic hypercalciuria, hyperuricosuria, or no metabolic disorder Ann Intern Med 87 1977 404
27. F.L. Coe J.M. Canterbury J.J. Firpo Evidence for secondary hyperparathyroidism in idiopathic hypercalciuria J Clin Invest 52 1973 134
28. F.L. Coe E. Moran A.G. Kavalich The contribution of dietary purine over-consumption to hyperuricosuria in calcium oxalate stone formers J Chron Dis 29 1976 793
29. M. Cohanim E. Yendt Reduction of urine oxalate during long-term thiazide therapy in patients with calcium urolithiasis Invest Urol 18 1980 170
30. L.S. Costanzo I.M. Weiner On the hypocalciuric action of chlorothiazide J Clin Invest 54 1974 628
31. L.S. Costanzo E. Windhager Calcium and sodium transport by the distal convoluted tubule of the rat Am J Physiol 235 1978 F492
32. G.C. Curhan S.G. Curhan Dietary factors and kidney stone formation Compr Ther 20 1994 485
33. W.J.C. Currie P. Turmer The frequency of renal stones within Great Britain in a gouty and non-gouty population Br J Urol 51 1979 337
34. M.I. Dauleh N.H. Townell Laparoscopic nephrectomy and nephro-ureterectomy: Argument for morselation or retrieval of intact specimens Min Inv Ther 3 1994 51
35. C.E. Dent T.C.B. Stamp Treatment of primary hyperoxaluria Arch Dis Child 45 1970 735
36. J.W. Dobbins H. Binder Effect of bile salts and fatty acids on the colonic absorption of oxalate Gastroenterology 70 1976 1096
37. F.J. Dudley C.R. Blackburn Extraskeletal calcification complicating oral neutral-phosphate therapy Lancet 2 1970 628
38. B.R. Edwards P.G. Baer R.A.L. Sutton Micropuncture study of diuretic effects on sodium and calcium reabsorption in the dog nephron J Clin Invest 52 1973 2418
39. N.A. Edwards R.G.G. Russell A. Hodgkinson The effect of oral phosphate in patients with recurrent renal calculus Br J Urol 37 1965 390
40. U. Ehrig J.E. Harrison D.R. Wilson Effect of long term thiazide therapy on intestinal calcium absorption in patients with recurrent renal calculi Metabolism 23 1974 139
41. I. Elomaa M. Ala-Opas L. Porkka Five years of experience with selective therapy in recurrent calcium nephrolithiasis J Urol 132 1984 656
42. B. Ettinger Recurrent nephrolithiasis: Natural history and effect of phosphate therapy Am J Med 61 1976 200
43. B. Ettinger J.T. Citron B. Livermore Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not J Urol 139 1988 679
44. B. Ettinger N.O. Oldroyd F. Sörgel Triamterene nephrolithiasis JAMA 244 1980 2443
45. B. Ettinger A. Tang J.T. Citron Randomized trial of allopurinol in the prevention of calcium oxalate calculi N Engl J Med 315 1986 1386
46. B. Ettinger E. Weil N.S. Mandel Triamterene-induced nephrolithiasis Ann Intern Med 91 1979 745
47. W.P. Evans M.I. Resnick Horseshoe kidney and urolithiasis J Urol 125 1981 620
48. B. Fellström B.G. Danielson B. Karlström Effects of high intake of dietary animal protein on mineral metabolism and urinary supersaturation of calcium oxalate in renal stone formers Br J Urol 56 1984 263
49. H.A. Fuselier D.M. Ward J.S. Lindberg Urinary Tamm-Horsfall protein increased after potassium citrate therapy in calcium stone formers Urology 45 1995 942
50. J.C. Gallagher B.E.C. Nordin Treatment with oestrogens of primary hyperparathyroidism in post-menopausal women Lancet 1 1972 503
51. J.M. Ginalski L. Portmann P. Jaeger Does medullary sponge kidney cause nephrolithiasis? AJR Am J Roentgenol 155 1990 299
52. R.W. Gray D.R. Wilz A.E. Caldas The importance of phosphate in regulating plasma 1,25-(OH)2vitamin D levels in humans: Studies in healthy subjects in calcium-stone formers and in patients with primary hyperparathyroidism J Clin Endocrinol Metab 45 1977 299
53. L.L. Hamm Renal handling of citrate Kidney Int 38 1990 728
54. J.A. Harvey K.D. Hill C.Y.C. Pak Similarity of urinary risk factors among stone-forming patients in five regions of the United States J Lithotr Stone Dis 2 1990 124
55. J.A. Harvey M.M. Zobitz C.Y.C. Pak Bioavailability of citrate from two different preparations of potassium citrate J Clin Pharmacol 29 1989 338
56. J.A. Harvey M.M. Zobitz C.Y.C. Pak Calcium citrate: Reduced propensity for the crystallization of calcium oxalate in urine resulting from induced hypercalciuria of calcium supplementation J Clin Endocrinol Metab 61 1985 1223
57. M. Hatch D. Vaziri Do thiazides reduce intestinal oxalate absorption?: A study in vitro using rabbit colon Clin Sci 86 1994 353
58. R. Hautmann F.J. Hering W. Lutzeyer Calcium oxalate stone disease: Effects and side effects of cellulose phosphate and succinate in long-term treatment of absorptive hypercalciuria or hyperoxaluria J Urol 120 1978 712
59. C. Henriksson K. Geterud S. Pettersson Stone recurrences in kidneys made stone-free by percutaneous extraction Scand J Urol Nephrol 27 1993 151
60. E. Higashihara Y. Aso J. Shimazaki Clinical aspects of polycystic disease J Urol 147 1992 329
61. E. Higashihara K. Nutahara T. Takeuchi Calcium metabolism in acidotic patients induced by carbonic anhydrase inhibitors: Responses to citrate J Urol 145 1991 942
62. D.H. Hosking S.B. Erickson Van den Berg C.J. The stone clinic effect in patients with idiopathic calcium urolithiasis J Urol 130 1983 1115
63. C. Hughes S. Dutton A.S. Truswell High intakes of ascorbic acid and urinary oxalate J Hum Nutr 35 1981 274
64. K.L. Insogna A.S. Ellison W.J. Burtis Trichlormethiazide and oral phosphate therapy in patients with absorptive hypercalciuria J Urol 141 1989 269
65. K. Jarrar V. Graef R.H. Boedeker Magnesium therapy in calcium-oxalate stone patients Walker V.R. Sutton R.A.L. Cameron E.C.B. Urolithiasis 1989 Plenum Press New York 853
66. C.M. Johnson D.M. Wilson W.M. O'Fallon Renal stone epidemiology: A 25 year study in Rochester, Minnesota Kidney Int 16 1979 624
67. R.A. Kaplan W.H. Snyder A. Stewart Metabolic effects of parathyroidectomy on asymptomatic primary hyperparathyroidism J Clin Endocrinol Metab 42 1976 415
68. S.R. Khan P.N. Shevock R.L. Hackett Magnesium oxide administration and prevention of calcium oxalate nephrolithiasis J Urol 149 1993 412
69. J. Khatchadourian G.M. Preminger P.A. Whitson Clinical and biochemical presentation of gouty diathesis: Comparison of uric acid versus pure calcium stone formation J Urol 154 1995 1665
70. R.T. Kunau D.R. Weller H.L. Webb Clarification of the site of action of chlorothiazide in the rat nephron J Clin Invest 56 1975 401
71. E. Laerum Metabolic effects of thiazide versus placebo in patients under long-term treatment for recurrent urolithiasis Scand J Urol Nephrol 18 1984 143
72. N.A. Laminski A.M. Meyers M. Kruger Hyperoxaluria in patients with recurrent calcium oxalate calculi: Dietary and other risk factors Br J Urol 68 1991 454
73. Lemann J. Jr R.W. Gray J.A. Pleuss Potassium bicarbonate, but not sodium bicarbonate, reduces urinary calcium excretion and improves calcium balance in healthy men Kidney Int 35 1989 688
74. D. Leppla R. Browne K. Hill Effect of amiloride with or without hydrochlorothiazide on urinary calcium and saturation of calcium salts J Clin Endocrinol Metab 57 1983 920
75. E. Levine J.J. Grantham Calcified renal stones and cyst calcification in autosomal dominant polycystic kidney disease: Clinical and CT study in 84 patients AJR Am J Roentgenol 159 1992 77
76. J. Lindberg J. Harvey C.Y.C. Pak Effect of magnesium citrate and magnesium oxide on the crystallization of calcium salts in urine: Changes produced by food-magnesium interaction J Urol 143 1990 248
77. R.W. Marshall M. Cochran A. Hodgkinson Relationships between calcium and oxalic acid intake in the diet and their excretion in the urine of normal and renal-stone-forming subjects Clin Sci 43 1972 91
78. G. Maschio N. Tessitore A. D'Angelo Prevention of calcium nephrolithiasis with low-dose thiazide, amiloride and allopurinol Am J Med 71 1981 623
79. L.K. Massey H. Roman-Smith R.A.L. Sutton Effect of dietary oxalate and calcium on urinary oxalate and risk of formation of calcium oxalate kidney stones J Am Diet Assoc 93 1993 901
80. J.C. McDonald M.D. Landreneau M.S. Rohr Reversal by liver transplantation of the complications of primary hyperoxaluria as well as the metabolic defect N Engl J Med 321 1989 1100
81. J.L. Meyer L.H. Smith Growth of calcium oxalate crystals Invest Urol 13 1975 36
82. F.P. Muldowney R. Freaney M.F. Moloney Importance of dietary sodium in the hypercalciuria syndrome Kidney Int 22 1982 292
83. M.J. Nicar M.C. Hsu Urinary response to oral potassium citrate therapy for urolithiasis in a private practice setting Clin Ther 8 1986 219
84. M.J. Nicar R. Peterson C.Y.C. Pak Use of potassium citrate as potassium supplement during thiazide therapy of calcium nephrolithiasis J Urol 131 1984 430
85. A. Norlin B. Lindell P. Granberg Urolithiasis. A study of its frequency Scand J Urol Nephrol 10 1976 150
86. M. O'Neill N.A. Breslau C.Y.C. Pak Metabolic evaluation of nephrolithiasis in patients with medullary sponge kidney JAMA 245 1981 1233
87. C.Y.C. Pak A cautious use of sodium cellulose phosphate in the management of calcium nephrolithiasis Invest Urol 19 1981 187
88. C.Y.C. Pak Citrate and renal calculi Miner Electrolyte Metab 13 1987 257
89. C.Y.C. Pak Role of medical prevention J Urol 141 1989 798
90. C.Y.C. Pak Sodium cellulose phosphate: Mechanism of action and effect on mineral metabolism J Clin Pharmacol 13 1973 15
91. C.Y.C. Pak D.E. Barilla K. Holt Effect of oral purine load and allopurinol on the crystallization of calcium salts in urine of patients with hyperuricosuric calcium urolithiasis Am J Med 65 1978 593
92. C.Y.C. Pak F. Britton R. Peterson Ambulatory evaluation of nephrolithiasis: Classification, clinical presentation and diagnostic criteria Am J Med 60 1980 19
93. C.Y.C. Pak C. Fuller Idiopathic hypocitraturic calcium oxalate nephrolithiasis successfully treated with potassium citrate Ann Intern Med 104 1986 33
94. C.Y.C. Pak C. Fuller K. Sakhaee Long-term treatment of calcium nephrolithiasis with potassium citrate J Urol 134 1985 11
95. C.Y.C. Pak R.A. Galosy Propensity for spontaneous nucleation of calcium oxalate: Quantitative assessment by urinary FPR-APR score Am J Med 69 1980 681
96. C.Y.C. Pak K. Holt F. Britton Assessment of pathogenetic roles of uric acid, monopotassium urate, monoammonium urate and monosodium urate in hyperuricosuric calcium oxalate nephrolithiasis Miner Electrolyte Metab 4 1980 130
97. C.Y.C. Pak M.J. Nicar C. Northcutt The definition of the mechanism of hypercalciuria is necessary for the treatment of recurrent stone formers Contrib Nephrol 33 1982 136
98. C.Y.C. Pak P. Peters G. Hurt Is selective therapy of recurrent nephrolithiasis possible? Am J Med 71 1981 615
99. C.Y.C. Pak R. Peterson Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate Arch Intern Med 146 1986 863
100. C.Y.C. Pak R. Peterson K. Sakhaee Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis Am J Med 79 1985 284
101. C.Y.C. Pak B. Ruskin E. Diller Enhancement of renal excretion of zinc by hydrochlorothiazide Clin Chim Acta 39 1972 511
102. C.Y.C. Pak K. Sakhaee C. Crowther Evidence justifying a high fluid intake in treatment of nephrolithiasis Ann Intern Med 93 1980 36
103. A.M. Parfitt Acetazolamide and sodium bicarbonate induced nephrocalcinosis and nephrolithiasis Arch Intern Med 124 1969 736
104. K.M. Patel Triamterene nephrolithiasis complicating dyazide therapy J Urol 126 1981 230
105. J.C. Pen˜a M.F. Monforte A. Bricen˜o The role of oxalate and calcium oxalate activity and formation product ratio in patients with renal stones before and during treatment J Urol 138 1987 1137
106. Pitts W.F. Jr E.C. Muecke Horseshoe kidneys: A 40-year experience J Urol 113 1975 743
107. G.M. Preminger C.Y.C. Pak Eventual attenuation of hypocalciuric response to hydrochlorothiazide in absorptive hypercalciuria J Urol 137 1987 1104
108. G.M. Preminger K. Sakhaee C.Y.C. Pak Alkali action on the urinary crystallization of calcium salts: Contrasting responses to sodium citrate and potassium citrate J Urol 139 1988 240
109. G.M. Preminger K. Sakhaee C. Skurla Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis J Urol 134 1985 20
110. D.S. Rao B. Frame M.A. Block Primary hyperparathroidism. A cause of hypercalciuria and renal stones in patients with medullary sponge kidney JAMA 237 1977 1353
111. W.G. Robertson M. Peacock The cause of idiopathic calcium stone disease: Hypercalciuria or hyperoxaluria Nephron 26 1980 105
112. W.G. Robertson M. Peacock P.J. Heyburn Should recurrent calcium oxalate stone formers become vegetarians? Br J Urol 51 1979 427
113. K. Sakhaee R. Alpern H.R. Jacobson Contrasting effects of various potassium salts on renal citrate excretion J Clin Endocrinol Metab 72 1991 396
114. K. Sakhaee J.A. Harvey P.K. Padalino Potential role of salt abuse on the risk for kidney stone formation J Urol 150 1991 310
115. K. Sakhaee S. Nigam P. Snell Assessment of the pathogenetic role of physical exercise in renal stone formation J Clin Endocrinol Metab 66 1987 974
116. Schmidt K.-H. V. Hagmaier D.H. Hornig Urinary oxalate excretion after large intakes of ascorbic acid in man Am J Clin Nutr 34 1981 305
117. K. Scholz P.O. Schwille A. Sigel Double-blind study with thiazide therapy in recurrent calcium nephrolithiasis J Urol 128 1982 903
118. P.O. Schwille U. Herrmann Environmental factors in the pathophysiology of recurrent idiopathic calcium urolithiasis (RCU), with emphasis on nutrition Urol Res 20 1992 72
119. P.L. Selby M. Peacock Ethinyl estradiol and norethindrone in the treatment of primary hyperparathyroidism in postmenopausal women N Engl J Med 314 1986 1481
120. F.H. Shen D.J. Baylink R.L. Neilson Increased serum 1,25-dihydroxyvitamin D in idiopathic hypercalciuria J Lab Clin Med 90 1977 955
121. J. Silver M.M. Friedlaender D. Rubinger Sodium-dependent idiopathic hypercalciuria in renal-stone formers Lancet 2 1983 484
122. L. Silver H. Brendler Use of magnesium oxide in management of familial hyperoxaluria J Urol 106 1971 274
123. L.H. Smith Hyperoxaluric states Coe F.L. Favus M.J. Disorders of Bone and Mineral Metabolism 1992 Raven Press New York 707
124. A.L. Strauss F.L. Coe L. Deutsch Factors that predict relapse of calcium nephrolithiasis during treatment: A prospective study Am J Med 71 1982 17
125. Stuart R.O. II K. Hill J. Poindexter Seasonal variations in urinary risk factors among patients with nephrolithiasis J Lithotr Stone Dis 3 1991 18
126. R.A.L. Sutton V.R. Walker Enteric and mild hyperoxaluria Miner Electrolyte Metab 20 1994 352
127. K. Suzuki R. Tsugawa R.L. Ryall Inhibition by sodium-potassium citrate (CG-120) of calcium oxalate crystal growth on to kidney stone fragments obtained from extracorporeal shock wave lithotripsy Br J Urol 68 1991 132
128. Thomas W.C. Jr Use of phosphates in patients with calcareous renal calculi Kidney Int 13 1978 390
129. V.E. Torres S.B. Erickson L.H. Smith The association of nephrolithiasis and autosomal dominant polycystic kidney disease Am J Kidney Dis 11 1988 318
130. M. Urivetzky S. Braverman J.A. Motola Urinary excretion of oxalate by patients with renal hypercalciuric stone disease Urol 37 1991 327
131. Van Den Berg C.J. R. Kumar C.M. Wilson Orthophosphate therapy decreases urinary calcium excretion and serum 1,25-dihydroxyvitamin D concentrations in idiopathic hypercalciuria J Clin Endocrinol Metab 51 1989 998
132. R. Vathsala S. Sindhu K. Sachidev Pyridoxine in the long-term follow-up of crystalluric stone formers Walker V.R. Sutton R.A.L. Cameron E.C.B. Urolithiasis 1989 Plenum Press New York 851
133. C.L. Wabner C.Y.C. Pak Effect of orange juice consumption on urinary stone risk factors J Urol 149 1993 1405
134. R.W.E. Watts R.Y. Calne R. Williams Primary hyperoxaluria (Type I): Attempted treatment by combined hepatic and renal transplantation Q J Med 57 1985 697
135. R.W.E. Watts R.A. Chalmers D.A. Gibbs Studies on some possible biochemical treatments of primary hyperoxaluria Q J Med 48 1979 259
136. R.W.E. Watts S.H. Morgan C.J. Danpure Combined hepatic and renal transplantation in primary hyperoxaluria Type I: Clinical report of nine cases Am J Med 90 1991 179
137. P.G. Werness J.H. Bergert L.H. Smith Triamterene urolithiasis: Solubility, pK, effect on crystal formation, and matrix binding of triamterene and its metabolites J Lab Clin Med 99 1982 254
138. D.J. White G.H. Nancollas Triamterene and renal stone formation J Urol 127 1982 593
139. D.J. White G.H. Nancollas Triamterene and renal stone formation: The influence of triamterene and triamterene stones on calcium oxalate crystallization Calcif Tissue Int 40 1987 79
140. R.C. Williams Long-term survey of 538 patients with upper urinary tract stones Br J Urol 35 1963 416
141. E.R. Yendt Medullary sponge kidney Gardner K.D. Jr Bernstein J. The Cystic Kidney 1990 Kluwer Academic Publishers The Netherlands 379
142. E.R. Yendt M. Cohanim Absorptive hyperoxaluria: A new clinical entity—successful treatment with hydrochlorothiazide Clin Invest Med 9 1986 44
143. E.R. Yendt M. Cohanim Prevention of calcium stones with thiazides Kidney Int 13 1978 397
144. E.R. Yendt G.F. Guay D.A. Garcia The use of thiazides in the prevention on renal calculi Can Med Assoc J 102 1970 614
145. T. Yu¨ A.B. Gutman Uric acid nephrolithiasis in gout Ann Intern Med 67 1967 1133
146. P.M. Zarembski A. Hodgkinson Some factors influencing the urinary excretion of oxalic acid in man Clin Chim Acta 25 1969 1
147. J.E. Zerwekh K. Holt C.Y.C. Pak Attenuation by monosodium urate of the inhibitory effect of glycosaminoglycans on calcium oxalate nucleation Invest Urol 17 1979 138
148. J.E. Zerwekh C.Y.C. Pak Selective effects of thiazide therapy on serum 1 alpha,25—dihydroxyvitamin D and intestinal calcium absorption in renal and absorptive hypercalciurias Metabolism 29 1980 13